Long COVID: major findings, mechanisms and recommendations.
Davis, Hannah E, McCorkell, Lisa, Vogel, Julia Moore et al. · Nature reviews. Microbiology · 2023 · DOI
Quick Summary
Long COVID is a serious illness affecting at least 10% of people who had COVID-19, with an estimated 65 million people worldwide experiencing it. The condition causes over 200 different symptoms affecting many body systems, similar to ME/CFS and other post-viral illnesses. This review examines what scientists have learned about Long COVID's causes and effects, though better diagnostic tests and treatments are still urgently needed.
Why It Matters
This comprehensive review strengthens the scientific foundation linking Long COVID to ME/CFS by documenting shared pathophysiological mechanisms across post-viral illnesses. For ME/CFS patients and researchers, it validates that Long COVID research advances directly inform understanding of ME/CFS and emphasizes the urgent need for validated biomarkers and effective treatments applicable to both conditions.
Observed Findings
At least 10% of SARS-CoV-2 infections progress to Long COVID, with an estimated 65 million cases worldwide
Over 200 distinct symptoms have been identified affecting multiple organ systems
Significant pathophysiological changes have been documented across various biomedical studies
Substantial overlap exists between Long COVID, ME/CFS, and postural orthostatic tachycardia syndrome
Variable symptom onset timing occurs across Long COVID patients
Inferred Conclusions
Long COVID and ME/CFS share common viral-onset mechanisms and pathophysiological features that warrant integrated research approaches
Current diagnostic and treatment frameworks are insufficient and require development of validated biomarkers and mechanistically-targeted therapies
Future Long COVID research must prioritize clinical trials addressing leading mechanistic hypotheses while addressing methodological biases and ensuring representative populations
Meaningful patient engagement throughout the research process is essential for advancing the field
Remaining Questions
What are the specific biomarkers that reliably distinguish Long COVID from other post-viral conditions and predict disease trajectory?
What This Study Does Not Prove
As a review article, this study does not present original experimental data and therefore cannot definitively prove causation for any specific Long COVID mechanism. The review acknowledges that current evidence remains insufficient to establish clear diagnostic criteria or recommend specific treatments, and the heterogeneity of Long COVID means findings may not apply equally to all patients.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →